2016
DOI: 10.1186/s13063-016-1156-0
|View full text |Cite
|
Sign up to set email alerts
|

Are glucose levels, glucose variability and autonomic control influenced by inspiratory muscle exercise in patients with type 2 diabetes? Study protocol for a randomized controlled trial

Abstract: BackgroundPhysical exercise reduces glucose levels and glucose variability in patients with type 2 diabetes. Acute inspiratory muscle exercise has been shown to reduce these parameters in a small group of patients with type 2 diabetes, but these results have yet to be confirmed in a well-designed study. The aim of this study is to investigate the effect of acute inspiratory muscle exercise on glucose levels, glucose variability, and cardiovascular autonomic function in patients with type 2 diabetes.Methods/des… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0
1

Year Published

2017
2017
2020
2020

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 52 publications
0
4
0
1
Order By: Relevance
“…Patients with type 1 diabetes CGM Reduced GV and improved protection against hypoglycemia [87][88][89] Insulin analogues degludec Minimized morning GV [91] Canagliflozin Improved indices of GV [92] Dapagliflozin over 24 weeks Improved GV without increasing the time spent in the range indicating hypoglycemia [93] Empagliflozin as adjunct to insulin Decreased glucose exposure and variability and increased time in glucose target range [103] Combination of basal insulin with ipragliflozin or dapagliflozin Improved TIR and the mean glucose level [104] Low carbohydrate diet Resulted in more time in euglycemia, less time in hypoglycemia [108][109][110] Patients with type 2 diabetes Dapagliflozin on 24-h Improved measures of GV [94] Once-weekly trelagliptin and once-daily alogliptin Improved glycemic control and reduced GV without inducing hypoglycemia [95] Combination of basal insulin with a GLP-1 RA Lowered GV and hypoglycemia [96] Exenatide once weekly Improved daily glucose control and reduced GV [97] Lixisenatide added to basal insulin Reduced GV and PPG excursions without increasing the risk of hypoglycemia [98] Liraglutide Lower mean time in hyperglycemia [99] Combination of metformin and gemigliptin or sitagliptin Significantly reduced GV [100] Vildagliptin or pioglitazone Significantly reduced MAGE, glycated hemoglobin and mean plasma glucose levels [101] Combination of metformin and vildagliptin or glimepiride Improved glucose level with a significantly greater reduction in GV and hypoglycemia [102] Intensive insulin therapy combined with metformin Reduced both glucose fluctuation and nocturnal hypoglycemic risk [105] Low-carbohydrate high-fat diet Reduced glycemic fluctuation [106,107,111] Sequence of food ingestion Associated with lower post-lunch glucose excursions and lower glucose coefficients of variation [115] Aerobic and combined exercise sessions Reduced glucose levels and GV [116][117][118] Short-term exercise training Improved glycemic control and GV but unaffected oxidative stress…”
Section: Measures Results Referencesmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients with type 1 diabetes CGM Reduced GV and improved protection against hypoglycemia [87][88][89] Insulin analogues degludec Minimized morning GV [91] Canagliflozin Improved indices of GV [92] Dapagliflozin over 24 weeks Improved GV without increasing the time spent in the range indicating hypoglycemia [93] Empagliflozin as adjunct to insulin Decreased glucose exposure and variability and increased time in glucose target range [103] Combination of basal insulin with ipragliflozin or dapagliflozin Improved TIR and the mean glucose level [104] Low carbohydrate diet Resulted in more time in euglycemia, less time in hypoglycemia [108][109][110] Patients with type 2 diabetes Dapagliflozin on 24-h Improved measures of GV [94] Once-weekly trelagliptin and once-daily alogliptin Improved glycemic control and reduced GV without inducing hypoglycemia [95] Combination of basal insulin with a GLP-1 RA Lowered GV and hypoglycemia [96] Exenatide once weekly Improved daily glucose control and reduced GV [97] Lixisenatide added to basal insulin Reduced GV and PPG excursions without increasing the risk of hypoglycemia [98] Liraglutide Lower mean time in hyperglycemia [99] Combination of metformin and gemigliptin or sitagliptin Significantly reduced GV [100] Vildagliptin or pioglitazone Significantly reduced MAGE, glycated hemoglobin and mean plasma glucose levels [101] Combination of metformin and vildagliptin or glimepiride Improved glucose level with a significantly greater reduction in GV and hypoglycemia [102] Intensive insulin therapy combined with metformin Reduced both glucose fluctuation and nocturnal hypoglycemic risk [105] Low-carbohydrate high-fat diet Reduced glycemic fluctuation [106,107,111] Sequence of food ingestion Associated with lower post-lunch glucose excursions and lower glucose coefficients of variation [115] Aerobic and combined exercise sessions Reduced glucose levels and GV [116][117][118] Short-term exercise training Improved glycemic control and GV but unaffected oxidative stress…”
Section: Measures Results Referencesmentioning
confidence: 99%
“…There is evidence that different types of exercise have various effects on glucose control. Schein et al performed a randomized clinical trial and found that inspiratory muscle training decreased glucose levels and GV in patients with type 2 diabetes, which could be a novel exercise modality [118]. Another crossover trial showed that short-term interval walking training improved CGM-derived GV compared with continuous walking training in individuals with type 2 diabetes [119].…”
Section: Exercise Trainingmentioning
confidence: 99%
“…Improvement in glycaemia and HbA1c with exercise is a commonly reported result [ 36 , 37 ]. Physical exercise is one of the most recommended non-pharmacological strategies for glycemic control in individuals with DM [ 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…This is a double blind crossover randomized clinical trial previously described in detail (Schein et al, 2016). Patients with type 2 DM were recruited from the Endocrinology Outpatient Clinic at Hospital de Clínicas de Porto Alegre (HCPA), Brazil and through website posting.…”
Section: Study Design/participantsmentioning
confidence: 99%